hemoglobin D disease
ORPHA: 900391 Treatment Available
Overview
Human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Crizanlizumab Orphan Cold Chain | IV infusion, 5mg/mL | FDA Approved | 3 | 14d |
Clinical Presentation
Signs and symptoms associated with hemoglobin D disease, sourced from HPO and Orphanet clinical annotations.
Imbalanced hemoglobin synthesisAbnormal hemoglobinReduced hemoglobin AReduced beta/alpha synthesis ratioReduced alpha/beta synthesis ratioDecreased mean corpuscular volumeDecreased mean corpuscular hemoglobin concentrationIncreased HbA2 hemoglobinSickled erythrocytesHbS hemoglobinPallorSplenomegalyAnemiaAbdominal pain
Classification & Codes
Orphanet Code
ORPHA:90039hemoglobin D disease
| Orphanet | ORPHA:90039 |
| Treatments | 1 drug(s) |
| Symptoms on record | 14 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO